Seroconversion after influenza vaccination in patients with lung cancer.
| dc.contributor.author | Anderson, Heather | |
| dc.contributor.author | Petrie, K | |
| dc.contributor.author | Berrisford, C | |
| dc.contributor.author | Charlett, A | |
| dc.contributor.author | Thatcher, Nick | |
| dc.contributor.author | Zambon, M | |
| dc.date.accessioned | 2010-07-12T15:40:50Z | |
| dc.date.available | 2010-07-12T15:40:50Z | |
| dc.date.issued | 1999-04 | |
| dc.identifier.citation | Seroconversion after influenza vaccination in patients with lung cancer. 1999, 80 (1-2):219-20 Br J Cancer | en |
| dc.identifier.issn | 0007-0920 | |
| dc.identifier.pmid | 10389999 | |
| dc.identifier.doi | 10.1038/sj.bjc.6690342 | |
| dc.identifier.uri | http://hdl.handle.net/10541/107513 | |
| dc.description.abstract | There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers. | |
| dc.language.iso | en | en |
| dc.subject | Lung Cancer | en |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Antibodies, Viral | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Influenza Vaccines | |
| dc.subject.mesh | Influenza, Human | |
| dc.subject.mesh | Lung Neoplasms | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Vaccination | |
| dc.title | Seroconversion after influenza vaccination in patients with lung cancer. | en |
| dc.type | Article | en |
| dc.contributor.department | Medical Oncology, Wythenshawe Hospital, Manchester, UK. | en |
| dc.identifier.journal | British Journal of Cancer | en |
| html.description.abstract | There are no data in the literature about the efficacy of influenza vaccination in lung cancer patients. Paired sera were available from 59 patients who received Fluvirin (Evans Medical). Of 41 patients susceptible to one or more influenza strains, 78% responded fully to vaccination. This response rate is comparable to that obtained from healthy volunteers. |